These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18701730)

  • 1. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.
    King WD; Minor P; Ramirez Kitchen C; Oré LE; Shoptaw S; Victorianne GD; Rust G
    J Epidemiol Community Health; 2008 Sep; 62(9):798-803. PubMed ID: 18701730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
    Kahn JG; Zhang X; Cross LT; Palacio H; Birkhead GS; Morin SF
    Public Health Rep; 2002; 117(3):252-62; discussion 231-2. PubMed ID: 12432136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
    Lillie-Blanton M; Stone VE; Snow Jones A; Levi J; Golub ET; Cohen MH; Hessol NA; Wilson TE
    Am J Public Health; 2010 Aug; 100(8):1493-9. PubMed ID: 19910347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
    Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for elimination of racial-ethnic disparities in HIV treatment initiation in the Medicaid population among 14 southern states.
    Zhang S; McGoy SL; Dawes D; Fransua M; Rust G; Satcher D
    PLoS One; 2014; 9(4):e96148. PubMed ID: 24769625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
    Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
    Turner BJ; Fleishman JA
    J Gen Intern Med; 2006 Dec; 21(12):1235-41. PubMed ID: 17105522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006.
    Oramasionwu CU; Brown CM; Lawson KA; Ryan L; Skinner J; Frei CR
    South Med J; 2011 Dec; 104(12):794-800. PubMed ID: 22089356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
    Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
    AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antiretroviral use in the United States of America: analysis of three observational databases.
    Ghani AC; Donnelly CA; Anderson RM
    HIV Med; 2003 Jan; 4(1):24-32. PubMed ID: 12534956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.
    Crystal S; Sambamoorthi U; Moynihan PJ; McSpiritt E
    J Gen Intern Med; 2001 Dec; 16(12):850-9. PubMed ID: 11903765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women.
    Anastos K; Schneider MF; Gange SJ; Minkoff H; Greenblatt RM; Feldman J; Levine A; Delapenha R; Cohen M;
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):537-44. PubMed ID: 16044004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies.
    Morin SF; Sengupta S; Cozen M; Richards TA; Shriver MD; Palacio H; Kahn JG
    Public Health Rep; 2002; 117(3):263-72; discussion 231-2. PubMed ID: 12432137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.
    Eisenman D; Bogart LM; Bird CE; Collins RL; Golinelli D; Fremont A; Beckman R; Cunningham W
    AIDS Patient Care STDS; 2007 Jun; 21(6):390-9. PubMed ID: 17594248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-related medical service use by rural/urban residents: a multistate perspective.
    Wilson LE; Korthuis T; Fleishman JA; Conviser R; Lawrence PB; Moore RD; Gebo KA
    AIDS Care; 2011 Aug; 23(8):971-9. PubMed ID: 21400307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in antiretroviral prescribing for blacks and whites in the United States.
    Oramasionwu CU; Skinner J; Ryan L; Frei CR
    J Natl Med Assoc; 2009 Nov; 101(11):1140-4. PubMed ID: 19998643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of medical insurance and other factors with receipt of antiretroviral therapy.
    Keruly JC; Conviser R; Moore RD
    Am J Public Health; 2002 May; 92(5):852-7. PubMed ID: 11988459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.
    Lemly DC; Shepherd BE; Hulgan T; Rebeiro P; Stinnette S; Blackwell RB; Bebawy S; Kheshti A; Sterling TR; Raffanti SP
    J Infect Dis; 2009 Apr; 199(7):991-8. PubMed ID: 19220139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.
    Beer L; Mattson CL; Bradley H; Skarbinski J;
    Medicine (Baltimore); 2016 Mar; 95(13):e3171. PubMed ID: 27043679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.